Omega Fund Management as of Dec. 31, 2016
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 12 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | 32.5 | $40M | 2.6M | 15.40 | |
| Juno Therapeutics | 18.8 | $23M | 1.2M | 18.85 | |
| Egalet | 17.9 | $22M | 2.9M | 7.65 | |
| Fibrogen (FGEN) | 14.3 | $18M | 822k | 21.40 | |
| Nabriva Therapeutics | 5.5 | $6.8M | 1.1M | 5.96 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 4.2 | $5.1M | 495k | 10.40 | |
| Essa Pharma | 3.0 | $3.7M | 1.7M | 2.19 | |
| Pieris Pharmaceuticals | 1.9 | $2.4M | 1.7M | 1.40 | |
| Editas Medicine (EDIT) | 0.9 | $1.1M | 66k | 16.23 | |
| Dicerna Pharmaceuticals | 0.5 | $644k | 224k | 2.88 | |
| Cymabay Therapeutics | 0.4 | $522k | 302k | 1.73 | |
| Proteon Therapeutics | 0.0 | $0 | 0 | 0.00 |
